期刊文献+

拟人参皂苷元对大鼠局灶性脑缺血损伤的保护作用 被引量:3

Protective effects of ocotillol on focal cerebral ischemic injury in rats
下载PDF
导出
摘要 目的观察拟人参皂苷元对大鼠局灶性脑缺血损伤的保护作用,并探讨其作用机制。方法缺血前给予拟人参皂苷元1.25、2.5、5、10、20mg.kg-1,灌胃7d,末次给药1h后制备大鼠大脑中动脉栓塞局灶性缺血模型(MCAO),12h后测定大鼠脑梗死面积并进行脑组织病理观察,制备脑组织匀浆测定超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量。结果大鼠脑缺血12h后,脑组织出现大面积梗死灶,且MDA含量增加,SOD活力降低。拟人参皂苷元(5mg.kg-1)能减小脑梗死面积,改善缺血损伤所致的脑组织病理形态学改变,并且降低缺血脑组织中MDA含量,升高SOD的活性。结论拟人参皂苷元对大鼠局灶性脑缺血损伤具有明显保护作用,该作用可能与抑制脂质过氧化、提高抗氧化酶活性有关。 Aim To observe the protective effects of ocotillol on focal cerebral ischemia in rats and to explore its possible mechanism. Methods Two hundred and fourty male Wistar rats were randomly divided into eight groups : sham group, ischemia group, nimodipine group and five ocotillol groups, to which ocotillol was administered at dose of 1.25,2. 5,5,10 and 20 mg· kg^-1, respectively. Middle cerebral artery occlusion (MCAO) was used to induce focal cerebral ischemia model. After 12 hours ischemia,infarction area of brain was assessed in brain slices stained with 2% solution of 2, 3, 5-triphenyl tetrazolium chloride (TTC). HE stain was used to observe the pathological changes in hippocampus region of ischemia rats. Superoxide dis-mustase ( SOD ) activity and malondialdehyde ( MDA ) content in homogenate of ischemic brain tissue were determined by spectrophotometric assay. Results Compared with ischemia group, ocotillol at a dose of 5 mg · kg^-1 could reduce the percentage of infarction area in the cerebral hemisphere, ameliorate the pathological changes in hippocampus CA1 area, increase SOD activity and decrease MDA content in ischemic brain tissue. Conclusions Ocotillol has protective effects on focal cerebral ischemic injury, and its mechanism may be related to the antioxidant action.
出处 《中国药理学通报》 CAS CSCD 北大核心 2008年第1期87-90,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No30572187)
关键词 脑缺血 抗氧化 自由基 大鼠 人参皂苷 cerebral ischemia antioxidant free radical rats ginsenoside
  • 相关文献

参考文献15

  • 1赵朝晖,陈晓春,金建生,朱元贵,师广斌,曾育琦,李永坤,彭旭.人参皂苷Rg1对细胞衰老过程中p21,cyclin E和CDK2表达的影响[J].药学学报,2004,39(9):673-676. 被引量:24
  • 2Attele A S,Wu J A,Yuan C S.Ginseng pharmacology:multiple constituents and multiple actions[J].Biochem Pharmacol,1999,58(11):1685-93.
  • 3Tian J,Fu F,Geng M,et al.Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats[J].Neurosci Lett,2005,374(2):92-7.
  • 4田京伟,傅风华,杨建雄.20(S)-人参皂苷Rg_3对脑缺血大鼠脑线粒体损伤的保护作用[J].中国药理学通报,2006,22(2):216-220. 被引量:17
  • 5Kim S,Ahn K,Oh T H,et al.Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons[J].Biochem Biophys Res Commun,2002,296(2):247-54.
  • 6Kim Y C,Kim S R,Markelonis G J,et al.Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration[J].J Neurosci Res,1998,53(4):426-32.
  • 7王金辉,李铣.拟人参皂苷F_(11)在大鼠体内的药物代谢研究[J].药学学报,2001,36(6):427-431. 被引量:13
  • 8马双刚,姜永涛,宋少江,王振华,白景,徐绥绪,刘珂.西洋参茎叶总皂苷碱降解成分[J].药学学报,2005,40(10):924-930. 被引量:20
  • 9Yanpallewar S U,Hota D,Rai S,et al.Nimodipine attenuates biochemical,behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats[J].Pharmacol Res,2004,49(2):143-50.
  • 10Longa E Z,Weinstein P R,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.

二级参考文献22

  • 1田京伟,傅风华,蒋王林,王超云,孙芳,张太平.羟基红花黄色素A对脑缺血所致大鼠脑线粒体损伤的保护作用[J].药学学报,2004,39(10):774-777. 被引量:41
  • 2王答祺,樊娟,冯宝树,李淑蓉,汪夕彬,杨崇仁,周俊.羽叶三七叶中甙类成分的研究[J].药学学报,1989,24(8):593-599. 被引量:10
  • 3奚涛,饶曼人.间硝地平对左室肥厚大鼠左室舒张功能及心脑线粒体和血管组织钙含量的影响[J].药学学报,1995,30(1):6-11. 被引量:7
  • 4[1]Masami K, Toshio M, Hisayuki T, et al. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of rats [J]. Chem Pharm Bull, 1991,39(2):400-404.
  • 5[2]Tsutomu O, Hisayuki T, Yoshi T, et al. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. IV. Decomposition of ginsenoside Rg1 and Rb1 in the digestive tract of rats [J]. Chem Pharm Bull, 1983,31(10):3691-3697.
  • 6[3]Seiji F, Ryoji K, Kazuhiro O, et al. Dammarane glycosides from aerial parts of Neoalsommitra integrifoliola [J]. Phytochemistry, 1995,38(2):465-472.
  • 7[4]Toshinobu M, Ryoji K, Osamu T, et al. Saponins of Iu-Feifeng, rhizomes of Panax japonicus C.A.Meyer Var major (Buek) C.Y.Wu at K.M.Feng, collected in yunnan, China [J]. Chem Pharm Bull, 1982,30(12):4341-4346.
  • 8[5]Ryu JH, Park JH, Eun JH, et al. A dammarane glycoside from korean red ginseng [J]. Phytochemistry, 1997,44(5):931-933.
  • 9[6]Masami K, Toshio M, Hisayuki T, et al. Studies on absorption, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large insestine of rats [J]. Chem Pharm Bull, 1990,38(10):2859-2861.
  • 10[7]Tsutomu O, Hisayuki T, Yoshio T. Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat [J]. Chem Pharm Bull, 1983,31(1):292-298.

共引文献82

同被引文献30

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部